HorwitzMitchell

A study led by Mitchell Horwitz, MD, professor of medicine (Hematologic Malignancies and Cellular Therapy), has found that umbilical cord blood stem cells that are cultured and expanded outside the body before being used for bone marrow transplant in adult blood cancer patients appear safe and restore blood count recovery faster than standard cord blood. The findings advance efforts to improve cord blood use among adults who have been diagnosed with blood cancers. 

Medicine Grand Rounds on Fri., March 28 at 8 a.m.

Subscribe to HorwitzMitchell